ALEMBIC Financial Statement Analysis
|
||
|
The Revenues of ALEMBIC have increased by 6.40% YoY .
The Earnings Per Share (EPS) of ALEMBIC has decreased by -14.22 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
ALEMBIC Last 5 Annual Financial Results
[BOM: 506235|NSE : ALEMBICLTD]
| Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹78 Cr | ₹74 Cr | ₹74 Cr | ₹124 Cr | ₹125 Cr |
| Expenses | ₹64 Cr | ₹63 Cr | ₹71 Cr | ₹106 Cr | ₹114 Cr |
| Operating Profit (Excl OI) | ₹14 Cr | ₹10 Cr | ₹3.14 Cr | ₹18 Cr | ₹11 Cr |
| Other Income | ₹89 Cr | ₹11 Cr | ₹94 Cr | ₹29 Cr | ₹37 Cr |
| Interest | ₹0.39 Cr | ₹0.36 Cr | ₹0.29 Cr | ₹0.22 Cr | ₹0.17 Cr |
| Depreciation | ₹4.86 Cr | ₹3.94 Cr | ₹3.23 Cr | ₹2.63 Cr | ₹3.78 Cr |
| Profit Before Tax | ₹98 Cr | ₹17 Cr | ₹93 Cr | ₹45 Cr | ₹44 Cr |
| Profit After Tax | ₹86 Cr | ₹14 Cr | ₹93 Cr | ₹41 Cr | ₹42 Cr |
| Consolidated Net Profit | ₹222 Cr | ₹343 Cr | ₹329 Cr | ₹213 Cr | ₹163 Cr |
| Earnings Per Share (Rs) | ₹7.42 | ₹8.65 | ₹13.35 | ₹12.82 | ₹8.30 |
| PAT Margin (%) | 63.36 | 110.20 | 18.83 | 125.85 | 33.18 |
| ROE(%) | 3.52 | 3.60 | 0.75 | 7.08 | 3.58 |
| ROCE(%) | 3.82 | 4.10 | 0.94 | 7.12 | 3.91 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 2,456.3 Cr |
| Revenue (TTM) | : | ₹ 145.6 Cr |
| Net Profit(TTM) | : | ₹ 76.3 Cr |
| EPS (TTM) | : | ₹ 3.0 |
| P/E (TTM) | : | 32.2 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| ALEMBIC | 0.5% | -21.6% | 37.1% |
| SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
| CIPLA | 2.5% | 0.4% | 71.7% |
| DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
| ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
| DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
| MANKIND PHARMA | NA | NA | NA |
| TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
| LUPIN | 2.8% | 0% | 147.8% |
ALEMBIC Revenues
[BOM: 506235|NSE : ALEMBICLTD]
| Y-o-Y | 6.40 % |
| 5 Yr CAGR | -11.11 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹78 Cr | 6.40 | |
| Mar2022 | ₹74 Cr | -0.55 | |
| Mar2021 | ₹74 Cr | -40.29 | |
| Mar2020 | ₹124 Cr | -1.19 | |
| Mar2019 | ₹125 Cr | - | |
ALEMBIC Operating Profit
[BOM: 506235|NSE : ALEMBICLTD]
| Y-o-Y | 33.59 % |
| 5 Yr CAGR | 5.89 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹14 Cr | 33.59 | |
| Mar2022 | ₹10 Cr | 232.07 | |
| Mar2021 | ₹3.14 Cr | -82.62 | |
| Mar2020 | ₹18 Cr | 63.10 | |
| Mar2019 | ₹11 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 25.60 % |
| 5 Yr CAGR | 19.14 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 17.81% | 25.60 | |
| Mar2022 | 14.18% | 233.65 | |
| Mar2021 | 4.25% | -70.87 | |
| Mar2020 | 14.59% | 65.05 | |
| Mar2019 | 8.84% | - | |
ALEMBIC Profit After Tax
[BOM: 506235|NSE : ALEMBICLTD]
| Y-o-Y | -35.23 % |
| 5 Yr CAGR | 8.04 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹222 Cr | -35.23 | |
| Mar2022 | ₹343 Cr | 4.17 | |
| Mar2021 | ₹329 Cr | 54.44 | |
| Mar2020 | ₹213 Cr | 30.76 | |
| Mar2019 | ₹163 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -42.50 % |
| 5 Yr CAGR | 17.55 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 63.36 % | -42.50 | |
| Mar2022 | 110.2 % | 485.24 | |
| Mar2021 | 18.83 % | -85.04 | |
| Mar2020 | 125.85 % | 279.29 | |
| Mar2019 | 33.18 % | - | |
ALEMBIC Earnings Per Share (EPS)
[BOM: 506235|NSE : ALEMBICLTD]
| Y-o-Y | -14.22 % |
| 5 Yr CAGR | -2.76 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹7.42 | -14.22 | |
| Mar2022 | ₹8.65 | -35.21 | |
| Mar2021 | ₹13 | 4.13 | |
| Mar2020 | ₹13 | 54.46 | |
| Mar2019 | ₹8.30 | - | |
ALEMBIC Return on Capital Employed (ROCE)
[BOM: 506235|NSE : ALEMBICLTD]
| Y-o-Y | -6.83 % |
| 5 Yr CAGR | -0.58 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 3.82% | -6.83 | |
| Mar2022 | 4.1% | 336.17 | |
| Mar2021 | 0.94% | -86.80 | |
| Mar2020 | 7.12% | 82.10 | |
| Mar2019 | 3.91% | - | |
ALEMBIC Share Price vs Sensex
| Current Share Price | : | ₹95.7 |
| Current MarketCap | : | ₹ 2,456.3 Cr |
| Updated EOD on | : | Apr 24,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC | 0.5% |
-21.6% |
37.1% |
| SENSEX | 1.3% |
2.6% |
24% |
ALEMBIC related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE SMALL CAP | 3.2% | 12.8% | 65.7% |
| S&P BSE MIDSMALLCAP | 2.4% | 10.7% | 64.9% |
| S&P BSE CONSUMER DISC. | 1.7% | 8.7% | 60.4% |
| S&P BSE ALLCAP | 1.6% | 6% | 40.6% |
No NSE index found
You may also like the below Video Courses
FAQ about ALEMBIC Financials
How the annual revenues of ALEMBIC have changed ?
The Revenues of ALEMBIC have increased by 6.40% YoY .
How the Earnings per Share (EPS) of ALEMBIC have changed?
The Earnings Per Share (EPS) of ALEMBIC has decreased by -14.22 % YoY .
Check out Intrinsic Value of Peers of ALEMBIC
Compare Stock Analytics of Peers of ALEMBIC
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
